Literature DB >> 31929993

Increasing mortality of intrahepatic cholangiocarcinoma in the US: are gender-specific risk factors important?

Samuel O Antwi1, Tushar Patel2.   

Abstract

Entities:  

Year:  2019        PMID： 31929993      PMCID： PMC6943003          DOI： 10.21037/hbsn.2019.10.10

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.

Authors:  Yasser H Shaib; Hashem B El-Serag; Jessica A Davila; Robert Morgan; Katherine A McGlynn
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

3.  International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Authors:  Jessica L Petrick; Megan Braunlin; Mathieu Laversanne; Patricia C Valery; Freddie Bray; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2016-06-28       Impact factor: 7.396

Review 4.  Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Authors:  Sumera Rizvi; Shahid A Khan; Christopher L Hallemeier; Robin K Kelley; Gregory J Gores
Journal:  Nat Rev Clin Oncol       Date:  2017-10-10       Impact factor: 66.675

5.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

Authors:  Yasser H Shaib; Jessica A Davila; Kathryn McGlynn; Hashem B El-Serag
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

6.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

7.  Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.

Authors:  Gia L Tyson; Jawad A Ilyas; Zhigang Duan; Linda K Green; Mamoun Younes; Hashem B El-Serag; Jessica A Davila
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

8.  Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.

Authors:  Samuel O Antwi; Omar Y Mousa; Tushar Patel
Journal:  Ann Hepatol       Date:  2018 July - August ,       Impact factor: 2.400

9.  Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry.

Authors:  Sasan Mosadeghi; Benny Liu; Taft Bhuket; Robert J Wong
Journal:  Hepatol Res       Date:  2015-11-12       Impact factor: 4.288

10.  Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma.

Authors:  Eliza W Beal; Dmitry Tumin; Dimitrios Moris; Xu-Feng Zhang; Jeffery Chakedis; Mary Dilhoff; Carl M Schmidt; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293
  10 in total
  2 in total

1.  The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients.

Authors:  Bao Jin; Wenmo Hu; Si Su; Haifeng Xu; Xin Lu; Xinting Sang; Huayu Yang; Yilei Mao; Shunda Du
Journal:  Cancer Manag Res       Date:  2021-08-10       Impact factor: 3.989

2.  Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study.

Authors:  Chun-Ru Lin; Yu-Kwang Lee; Chun-Ju Chiang; Ya-Wen Yang; Hung-Chuen Chang; San-Lin You
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.